Regulatorische Updates
Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit
#extended release ×
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
FDA Approves NESHER PHARMS Metoprolol Succinate ER Tablet (ANDA077176)
The FDA approved NESHER PHARMS' ANDA077176 for metoprolol succinate extended‑release tablets (50 mg eq). The product is listed as discontinued.
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
NESHER PHARMS ANDA077779 for Metoprolol Succinate ER Tablet Approved by FDA
FDA approved ANDA077779 for metoprolol succinate extended‑release tablets from NESHER PHARMS; product listed as discontinued.
Regulatorische Updates
27. Aug. 2026•1 Min. Lesezeit
FDA Announces Discontinued Alprazolam Extended‑Release Tablets (ANDA 077198)
The FDA’s ANDA 077198 for alprazolam extended‑release tablets submitted by Actavis Labs FL Inc shows all listed products as discontinued.